MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
暂无分享,去创建一个
P. Hegde | T. Powles | H. Burris | J. Bellmunt | D. Petrylak | N. Vogelzang | Y. Loriot | Daniel S Chen | G. Fine | Z. Boyd | J. Eder | F. Braiteh | C. Cruz | S. Teng | Xiao-dong Shen | Daniel S. Chen